Bioretec Oy (HEL:BRETEC)

Finland flag Finland · Delayed Price · Currency is EUR
0.288
-0.008 (-2.70%)
At close: Feb 26, 2026
-88.34%
Market Cap 8.41M
Revenue n/a
Net Income n/a
Shares Out 30.79M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 113,184
Average Volume 128,045
Open 0.296
Previous Close 0.296
Day's Range 0.282 - 0.297
52-Week Range 0.162 - 2.480
Beta 0.43
RSI 22.99
Earnings Date Feb 13, 2026

About Bioretec Oy

Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures; and ActivaScrew, an absorbable surgical implant that is used in fracture treatmen... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1998
Country Finland
Stock Exchange Nasdaq Helsinki
Ticker Symbol BRETEC
Full Company Profile

News

Bioretec Ltd (OHEL:BRETEC) Q4 2025 Earnings Report Preview: What To Expect

Bioretec Ltd (OHEL:BRETEC) Q4 2025 Earnings Report Preview: What To Expect

17 days ago - GuruFocus

Bioretec Board Approves Updated Strategy, Financial Targets For 2026-2028 Period

(RTTNews) - Bioretec (0TN.F, BRETEC.HE) said Board of Directors has approved the company's updated strategy for 2026-2028 and new financial targets for the strategy period. Bioretec's new financial ta...

2 months ago - Nasdaq

Bioretec Secures FDA Breakthrough Device Designation For RemeOs DrillPin

(RTTNews) - Bioretec Oy (0TN.F, BRETEC.HE) has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its magnesium alloy technology-based, biodegradable RemeO...

2 months ago - Nasdaq

Bioretec Ltd's business review Q1 2025: Strong net sales in the first quarter; CE approval with comprehensive indications received in January accelerates the future expansion of RemeOs products

Bioretec Ltd Company announcement 15 May 2025 at 8:00 a.m. TAMPERE, Finland , May 15, 2025 /PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for January- March 2025 . The com...

10 months ago - Benzinga